Wed, January 3, 2024

Joel Beatty Initiated (AMLX) at Buy and Held Target at $37 on, Jan 3rd, 2024

Joel Beatty of Baird, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Buy and Held Target at $37 on, Jan 3rd, 2024.

Joel has made no other calls on AMLX in the last 4 months.



There are 4 other peers that have a rating on AMLX. Out of the 4 peers that are also analyzing AMLX, 0 agree with Joel's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Joel


  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $27 on, Thursday, December 21st, 2023
  • Neena Bitritto-Garg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $36 on, Tuesday, December 12th, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $42 on, Friday, November 10th, 2023
  • Chris Shibutani of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Friday, November 10th, 2023